首页> Cancers> Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?

Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?

导出 OA

翻译打印收藏纠错

第一作者： Shelize,Khakoo

第一单位： Department of Medicine, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK.

作者： Shelize,Khakoo ^[1] ; Angelica,Petrillo ^[2] ; Massimiliano,Salati ^[3] ; Abdul,Muhith ^[1] ; Jessica,Evangelista ^[4] ; Silvia,Seghezzi ^[5] ; Fausto,Petrelli ^[6] ; Gianluca,Tomasello ^[7] ; Michele,Ghidini ^[7]

作者单位： Department of Medicine, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. ^[1] Division of Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy.;Oncology Unit, Ospedale del Mare, 80147 Naples, Italy. ^[2] Department of Oncology, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy. ^[3] Department of Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. ^[4] Nuclear Medicine Unit, ASST Bergamo Ovest, 24047 Treviglio, Italy. ^[5] Oncology Unit, Medical Sciences Department, ASST Bergamo Ovest, 24047 Treviglio, Italy. ^[6] Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. ^[7]

关键词 biomarkers immunotherapy neo-adjuvant chemotherapy pancreatic ductal adenocarcinoma radiotherapy resectability

DOI 10.3390/cancers13174396

PMID 34503206

发布时间 2021-09-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交